IPOs

Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
Fierce Biotech
Mon, 06/3/24 - 10:32 pm
Rapport Therapeutics
IPOs
epilepsy
Biopharma IPOs From the First Half of 2024
BioSpace
Thu, 05/30/24 - 11:17 am
IPOs
biotewch
CG Oncology
Kyverna Therapeutics
ArriVent Biopharma
Alto Neuroscience
Contineum Therapeutics
Boundless Bio
Fractyl Health
Metagenomi
Telomir
Rapport Therapeutics
Telix Pharmaceuticals
Clinical-stage cancer biotech Actuate latest to eye summer IPO
Fierce Biotech
Tue, 05/28/24 - 10:53 am
Actuate Therapeutics
IPOs
cancer
oncology
J&J-backed startup Rapport files for US IPO
Reuters
Sun, 05/19/24 - 10:41 pm
Rapport Therapeutics
JNJ
IPOs
Aardvark raises $85M to target hunger, not appetite, as it contemplates IPO, pharma deals
San Diego Biotech Networks
Thu, 05/9/24 - 07:37 pm
Aardvark Therapeutics
R&D
weight loss
IPOs
funding
CG follows big IPO with new results for bladder cancer drug
BioPharma Dive
Sun, 05/5/24 - 11:35 pm
CG Oncology
IPOs
bladder cancer
cretostimogene
‘Next wave of IPOs’ will arrive in summer, predicts biotech-focused VC partner
Fierce Biotech
Fri, 05/3/24 - 11:32 am
IPOs
biotech
Medicxi
CS Oncology
Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
BioSpace
Fri, 04/5/24 - 11:32 am
Contineum Therapeutics
IPOs
neuroinflammation
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Neuro and inflammation biotech Contineum Therapeutics sets terms for $150 million IPO
Renaissance Capital
Mon, 04/1/24 - 12:25 pm
IPOs
Contineum Therapeutics
IPF
multiple sclerosis
Boundless Bio breaks IPO lull with $100M fundraise
BioPharma Dive
Wed, 03/27/24 - 10:37 pm
Boundless Bio
IPOs
Bayer
Arch Venture Partners
cancer
Galderma sets IPO price at top of range, or 53 Swiss francs a share
Reuters
Thu, 03/21/24 - 11:40 am
Galderma
IPOs
Boundless Bio eyes $88M offering as spring biotech IPO market blooms
Fierce Biotech
Thu, 03/21/24 - 11:32 am
Boundless Bio
IPOs
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
BioPharma Dive
Thu, 03/7/24 - 11:13 am
Boundless Bio
IPOs
Bayer
Arch Venture Partners
Biotech IPOs heated up to start 2024. Will the surge last?
BioPharma Dive
Tue, 03/5/24 - 11:06 am
IPOs
biotech
Everyone's Talking About These 2 Biotech IPO Stocks
Motley Fool
Sun, 02/25/24 - 08:55 pm
biotech
IPOs
Kyverna Therapeutics
CG Oncology
Biopharma R&D Funding Has Rebounded But Clinical Trial Starts Slowed Down in 2023, Says IQVIA Institute
Managed Healthcare Executive
Thu, 02/22/24 - 11:21 pm
clinical trials
R&D
biotech
IPOs
IQVIA
4 biotechs to watch in 2024
Pharma Voice
Wed, 02/21/24 - 11:28 am
biotech
IPOs
Alto Neuroscience
Verona Pharma
Karuna Therapeutics
Madrigal Pharmaceuticals
precision medicine
COPD
Alzheimer's disease
NASH
Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut
BioSpace
Mon, 02/12/24 - 11:51 am
Metagenomi
Bayer
IPOs
Kyverna CEO Peter Maag on courting investors in a ‘volatile’ IPO market
BioPharma Dive
Mon, 02/12/24 - 11:47 am
Kyverna Therapeutics
IPOs
Peter Maag

Pages